Skip to main content
Premium Trial:

Request an Annual Quote

Peter Goodfellow

Premium
Decode Genetics has appointed Peter Goodfellow to its board of directors, effective immediately.
 
Goodfellow was until recently senior vice president for discovery research at GlaxoSmithKline. He has a PhD from Oxford University and held a postdoctoral fellowship at Stanford University.

Filed under

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.